← All organizations

Neogen

For profitWebsite ↗

Also known as: NeogenTC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

First marketed drug

Last known activity

Jun 3, 2026

Timeline

1980s

Jun 1, 1982
Neogen— Founded

2010s

Oct 2, 2012
Macleods Pharmaceuticals, Ltd— Acquired
Apr 19, 2013
valsartan— Marketing Organization
Jan 2, 2014
Chem Tech Research Incorporation— Acquired
Mar 25, 2019
dolutegravir— NDA Secondary Org

Drugs by trial phase (6 distinct, 5 trials)

Phase 4 (0 own, 1 via acquisition)

taltirelin tetrahydrate

Phase 3 (0 own, 1 via acquisition)

albuterol

Phase 2 (0 own, 1 via acquisition)

levofloxacin

Phase 1 (2 own, 1 via acquisition)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (1)

NCT06107894Lead sponsorPhase 1Jan 31, 2024

Details

Founded: Lansing, MI, US Jun 1, 1982
Last known activity: Jun 3, 2026